2,4-dimethoxyphenylsemicarbazones with anticonvulsant activity against three animal models of seizures: Synthesis and pharmacological evaluation

被引:76
作者
Thirumurugan, R
Sriram, D
Saxena, A
Stables, J
Yogeeswari, P [1 ]
机构
[1] Birla Inst Technol & Sci, Med Chem Res Lab, Pharm Grp, Pilani 333031, Rajasthan, India
[2] Natl Inst Hlth, Preclin Pharmacol Sect, Epilepsy Branch, Bethesda, MD 20892 USA
关键词
aryl semicarbazones; anticonvulsant; 2,4-dimethoxy; GABA;
D O I
10.1016/j.bmc.2005.12.041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various 2.4-dimethoxyphenylsemicarbazones were synthesized starting from 2,4-dimethoxyaniline via a phenylcarbamate intermediate. The structures were confirmed by spectral and elemental analyses. The anticonvulsant activity of the synthesized compounds was established after intraperitoneal administration in three seizure models in mice which include maximal electroshock seizure, Subcutaneous pentylenetetrazole, and subcutaneous strychnine-induced seizure screens. Nine Compounds exhibited protection in all the three seizure models, and N-1-(2,4-dimethoxyphenyl)-N-4-(propan-2-one)semicarbazone (17) emerged as the most active compound with no neurotoxicity. These compounds were found to elevate gamma-aminobutyric acid (GABA) levels in the midbrain and medulla oblongata regions equipotent to clobazam. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3106 / 3112
页数:7
相关论文
共 26 条
[11]   ANTICONVULSANT STRUCTURE-ACTIVITY-RELATIONSHIPS - HISTORICAL DEVELOPMENT AND PROBABLE CAUSES OF FAILURE [J].
JONES, GL ;
WOODBURY, DM .
DRUG DEVELOPMENT RESEARCH, 1982, 2 (04) :333-355
[13]   ANTIEPILEPTIC DRUG DEVELOPMENT .2. ANTICONVULSANT DRUG SCREENING [J].
KRALL, RL ;
PENRY, JK ;
WHITE, BG ;
KUPFERBERG, HJ ;
SWINYARD, EA .
EPILEPSIA, 1978, 19 (04) :409-428
[14]   STRATEGIES IN ANTIEPILEPTIC DRUG DEVELOPMENT - IS RATIONAL DRUG DESIGN SUPERIOR TO RANDOM SCREENING AND STRUCTURAL VARIATION [J].
LOSCHER, W ;
SCHMIDT, D .
EPILEPSY RESEARCH, 1994, 17 (02) :95-134
[15]   Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones [J].
Pandeya, SN ;
Yogeeswari, P ;
Stables, JP .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (10) :879-886
[16]   BEHAVIORAL DESPAIR IN RATS - NEW MODEL SENSITIVE TO ANTIDEPRESSANT TREATMENTS [J].
PORSOLT, RD ;
ANTON, G ;
BLAVET, N ;
JALFRE, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (04) :379-391
[17]   ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM [J].
PORTER, RJ ;
CEREGHINO, JJ ;
GLADDING, GD ;
HESSIE, BJ ;
KUPFERBERG, HJ ;
SCOVILLE, B ;
WHITE, BG .
CLEVELAND CLINIC QUARTERLY, 1984, 51 (02) :293-305
[18]  
ROBERTS E, 1962, METHOD ENZYMOL, V4, P612
[19]  
Wasterlain C., 1989, BASIC NEUROCHEMISTRY, P797
[20]   LOCOMOTOR-ACTIVITY IN MORPHINE-TREATED RATS - EFFECTS OF AND COMPARISONS BETWEEN COCAINE, PROCAINE, AND LIDOCAINE [J].
WIECHMAN, BE ;
WOOD, TE ;
SPRATTO, GR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (03) :425-433